Results 111 to 120 of about 1,188 (177)

Does combined pulmonary fibrosis and emphysema syndrome affect response to antifibrotic therapy and survival? A single-center retrospective cohort study. [PDF]

open access: yesSarcoidosis Vasc Diffuse Lung Dis
Teke NH   +11 more
europepmc   +1 more source

Dual pathology, dual burden: Functional impact of emphysema and fibrosis in Hypersensitivity Pneumonitis. [PDF]

open access: yesSarcoidosis Vasc Diffuse Lung Dis
Öztürk Ergür F   +4 more
europepmc   +1 more source

Korean Clinical Practice Guidelines for Interstitial Lung Disease: Part 2. Idiopathic Pulmonary Fibrosis. [PDF]

open access: yesTuberc Respir Dis (Seoul)
Choi HS   +8 more
europepmc   +1 more source

Pulmonary hypertension optimal screening in interstitial lung disease (PHOS-ILD): a scoring system for the detection of pulmonary hypertension in patients with interstitial lung disease. [PDF]

open access: yesFront Med (Lausanne)
Karampitsakos T   +19 more
europepmc   +1 more source

Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis. [PDF]

open access: yesRheumatology (Oxford)
Sauer GM   +9 more
europepmc   +1 more source

Impact of segmental location, fibrosis, and emphysema on predicting volume loss during lung resection. [PDF]

open access: yesJTCVS Open
Kumeda H   +10 more
europepmc   +1 more source

Secondary polycythemia as a rare cause of ischemic stroke: A case report. [PDF]

open access: yesRadiol Case Rep
Ben Chihi F   +4 more
europepmc   +1 more source

Enzalutamide-associated acute exacerbation of interstitial lung abnormality: a case report. [PDF]

open access: yesFront Med (Lausanne)
Meiduo S   +6 more
europepmc   +1 more source

Lung mTOR activation leads to lung fibrosis or emphysema via senescence of specific lung cells. [PDF]

open access: yesSci Rep
Houssaini A   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy